It is a pharma private limited company based in Csa, Uttar Pradesh, India, established in 2021.
2021 | Csa, Uttar Pradesh, India | ActiveAmbiens Pharmaceuticals Private Limited, a active private limited company, was established on 20 October 2021 in Csa, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909UP2021PTC154117. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Saurabh Misra (Additional Director), Nidhi Mittal (Additional Director), Kamla Kukreti (Additional Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3A/46-2C, Azad Nagar, Csa, Uttar Pradesh, 208002.
U51909UP2021PTC154117
154117
20 October 2021
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ambiens Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Misra | Additional Director | 18 Jan 2022 | Current |
| Nidhi Mittal | Additional Director | 16 Mar 2022 | Current |
| Kamla Kukreti | Additional Director | 16 Mar 2022 | Current |
| Prabhat Misra | Director | 20 Oct 2021 | Current |
| Prashant Pandey | Director | 20 Oct 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ambiens Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ambiens Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ambiens Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ambiens Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambiens Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ambiens Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Ambiens Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Nidhi Mittal was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
Kamla Kukreti was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.
Saurabh Misra was appointed as a Additional Director was appointed as a Additional Director on 18 Jan 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
Progress on Prabhat Misra was appointed as a Director was appointed as a Director on 20 Oct 2021 & has been associated with this company since 4 years 2 months . was documented.
The CIN of Ambiens Pharmaceuticals Private Limited is U51909UP2021PTC154117.
Ambiens Pharmaceuticals Private Limited is headquartered at 3A/46-2C, Azad Nagar, Csa, Uttar Pradesh, 208002.
Ambiens Pharmaceuticals Private Limited was incorporated on 20 October 2021.
The current directors of Ambiens Pharmaceuticals Private Limited are
The primary industry of Ambiens Pharmaceuticals Private Limited is Pharma.
Ambiens Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ambiens Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX